Long-Term Survival in Metastatic Pancreatic Adenocarcinoma of Intestinal Type
Journal of Clinical Medicine · 25.08.2024 · 13 (17) · 5034
DOI: 10.3390/jcm13175034 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Clinical Medicine, online erschienen am 25.08.2024. Verfasst von Gabriela Rahnea-Nita und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology-Palliative Care, "Sf. Luca" Chronic Diseases Hospital, 041915 Bucharest, Romania. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction and Literature Review: Pancreatic cancer is often diagnosed in an advanced/metastatic stage, as it is a very aggressive type of cancer. The prognosis of pancreatic cancer is extremely unfavorable. The mean survival rate for patients with metastatic pancreatic adenocarcinoma is 3–6 months. Stage IV pancreatic cancer has a five-year survival rate of 1.3% to 13%. This article presents recent data regarding the oncologic management of metastatic pancreatic cancer. Case presentation: We present the case of a female patient who was 49 years old at the time of diagnosis, in June 2021. The patient was diagnosed with stage IV pancreatic neoplasm (due to liver metastases). The diagnosis was made by histopathological and immunohistochemical examination, which corroborated imaging investigations. The patient underwent four lines of chemotherapy between July 2021 and July 2024, undergoing partial response to the disease. The patient is a long-term survivor of metastatic pancreatic cancer (3 years in July 2024). Discussions: the peculiarity of this case is long-term survival (3 years and a month at the date when this article is being written) in a patient with pancreatic cancer and liver metastases. Conclusions: histopathological type, good performance status, CEA, and CA tumor markers 19.9 within normal limits may be favorable prognostic factors for long-term survival in metastatic pancreatic carcinoma.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology-Palliative Care, "Sf. Luca" Chronic Diseases Hospital, 041915 Bucharest, Romania.
- Specific Disciplines Department, Faculty of Nursing and Midwifery, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Medical Clinical Department, Faculty of Medicine and Pharmacy, "Dunărea de Jos" University, 800008 Galaţi, Romania.
- Department of Radiotherapy, "Sf. Apostol Andrei" Hospital, 800578 Galaţi, Romania.
- 10th Clinical Department-General Surgery, Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
- Department of General Surgery, "Bagdasar-Arseni" Clinical Emergency Hospital, 041915 Bucharest, Romania.
ORCID-Profile: Ionuţ Simion Coman, Costin George Florea, Mircea Liţescu
Zitieren
APA
Rahnea-Nita, G., Rebegea, L. F., Grigorean, V. T., Coman, I. S., Coman, V. E., Pleşea, I. E., Erchid, A., Florea, C. G., Liţescu, M., & Rahnea-Nita, R. A. (2024). Long-Term Survival in Metastatic Pancreatic Adenocarcinoma of Intestinal Type. Journal of Clinical Medicine, 13(17), 5034. https://doi.org/10.3390/jcm13175034
Vancouver
Rahnea-Nita G, Rebegea LF, Grigorean VT, Coman IS, Coman VE, Pleşea IE, et al. Long-Term Survival in Metastatic Pancreatic Adenocarcinoma of Intestinal Type. Journal of Clinical Medicine. 2024;13(17):5034. doi:10.3390/jcm13175034
BibTeX
@article{RahneaNita2024,
author = {Rahnea-Nita, Gabriela and Rebegea, Laura-Florentina and Grigorean, Valentin Titus and Coman, Ionuţ Simion and Coman, Violeta Elena and Pleşea, Iancu Emil and Erchid, Anwar and Florea, Costin George and Liţescu, Mircea and Rahnea-Nita, Roxana-Andreea},
title = {Long-Term Survival in Metastatic Pancreatic Adenocarcinoma of Intestinal Type},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {17},
pages = {5034},
doi = {10.3390/jcm13175034}
}
EUVIMED